Pharmaceutical - Financial, Mergers & Acquisitions

Filter

Popular Filters

1 to 25 of 79 results

Pharma more optimistic about future despite upcoming industry consolidation

Pharma more optimistic about future despite upcoming industry consolidation

13-06-2014

More than 69% of senior players within the pan-world pharma industry expect to see a year-on-year increase…

FinancialGlobalMergers & AcquisitionsPharmaceutical

Takeover target Allergen reports strong 1st-qtr sales growth

07-05-2014

US drugmaker Allergan reported a strong set of first-quarter 2014 financial results, with global sales…

AllerganFinancialMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

AstraZeneca sets out its value stall, projecting annual revenues of $45 billion by 2023

AstraZeneca sets out its value stall, projecting annual revenues of $45 billion by 2023

06-05-2014

In a bid to explain its rejection of US pharma giant Pfizer’s increased takeover bid for the Anglo-Swedish…

AstraZenecaFinancialMergers & AcquisitionsPfizerPharmaceuticalResearch

Pfizer’s 4th-qtr 2014 profits and sales slump on generic competition

Pfizer’s 4th-qtr 2014 profits and sales slump on generic competition

06-05-2014

US pharma giant Pfizer, which is aggressively pursuing a takeover of Anglo-Swedish drug major AstraZeneca,…

AstraZenecaFinancialMergers & AcquisitionsPfizerPharmaceutical

Fresenius Kabi signs joint venture with Russia’s Binnopharm

Fresenius Kabi signs joint venture with Russia’s Binnopharm

28-04-2014

Germany-based health care group Fresenius Kabi is entering into a joint venture with Russia’s Sistema…

BinnopharmBusiness FinanceBusiness FinanceFinancialFreseniusFresenius KabiGermanyHealth careHealthcareMergers & AcquisitionsPharmaceuticalRussiaUSD

Allergan adopts stockholder rights plan

23-04-2014

USA-based Allergan, the subject of a hostile takeover bid from Canada’s Valeant Pharmaceuticals reported…

AllerganFinancialMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Amount of foreign direct investment proves India’s attraction to Big Pharma despite protestations on IP

Amount of foreign direct investment proves India’s attraction to Big Pharma despite protestations on IP

31-03-2014

Multinational drugmakers might be crying themselves hoarse that India does not protect innovation - that…

Asia-PacificBristol-Myers SquibbFinancialGlaxoSmithKlineIndiaMerck & CoMergers & AcquisitionsMylan LaboratoriesPatentsPharmaceuticalSanofi

Vectura to buy Germany’s Activaero for 130 million euros

Vectura to buy Germany’s Activaero for 130 million euros

14-03-2014

UK developer of inhaled therapies Vectura says it is acquiring privately-held German company Activaero…

ActivaeroFinancialMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

Fitch affirms Actavis at “BBB-” on Forest Labs acquisition; outlook Stable

20-02-2014

Fitch Ratings has affirmed the ratings of generic drugs major Actavis and subsidiaries at “BBB-”…

ActavisFinancialForest LaboratoriesMergers & AcquisitionsPharmaceutical

Increasing investment in Latin American pharma market

Increasing investment in Latin American pharma market

12-02-2014

Around $12.7 billion has been invested in Latin America’s pharmaceutical market through mergers and…

ArgentinaBrazilChileEcuadorFinancialMergers & AcquisitionsPharmaceuticalSouth America

Medigene’s buy of Trianta is “lucrative move” say analysts

31-01-2014

Medigene’s 4 million euro ($5.5 million) purchase of fellow German company Trianta Immunotherapies…

FinancialImmunologicalsMedigeneMergers & AcquisitionsOncologyPharmaceuticalTrianta ImmunotherapiesUSA

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds

22-01-2014

German pharma and life sciences group Bayer says it is taking advantage of currently low interest rates…

AlgetaBayerFinancialMergers & AcquisitionsPharmaceutical

NeXeption forms new company, Alexar Therapeutics, to develop novel LXR agonist portfolio

03-01-2014

US biopharma management company NeXeption says it has secured $21.5 million in Series A financing to…

A-110Alexar TherapeuticsDermatologicalsFinancialMergers & AcquisitionsNeXeptionPharmaceuticalResearch

OPKO takes 10-fold profit on sale of stake in Sorrento Therapeutics

20-12-2013

US drugmaker OPKO Health says it has completed the sale of its stake in Sorrento Therapeutics, a clinical-stage…

FinancialMergers & AcquisitionsOPKO HealthPharmaceuticalSorrento Therapeutics

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

28-11-2013

South African drugmaker Adcock Ingram yesterday made the case for accepting a takeover from Chile largest…

Adcock IngramCFR PharmaceuticalsFinancialMergers & AcquisitionsPharmaceuticalRest of the World

GlaxoSmithKline cashes in $694 million of Aspen shares

GlaxoSmithKline cashes in $694 million of Aspen shares

21-11-2013

UK pharma giant GlaxoSmithKline said yesterday that it has agreed to the sale of 28.2 million ordinary…

Aspen PharmacareFinancialGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Shire’s acquisition of ViroPharma will add $831m in revenue by 2018, says GlobalData

Shire’s acquisition of ViroPharma will add $831m in revenue by 2018, says GlobalData

19-11-2013

Ireland-based drugmaker Shire’s (LSE: SHP) buy-out of US orphan drug company ViroPharma (Nasdaq: VPHM)…

CinryzeEuropeFinancialMergers & AcquisitionsPharmaceuticalShireUSAViroPharma

Endo to acquire Paladin Labs in $1.6 billion deal

Endo to acquire Paladin Labs in $1.6 billion deal

06-11-2013

Shares of Endo Health Solutions leapt 29% to $56.22 by close of trading on November 5, after the company…

Endo Health SolutionsFinancialMergers & AcquisitionsPaladin LabsPharmaceutical

Savient files for voluntary bankruptcy protection; plans asset sale

15-10-2013

US drugmaker Savient Pharmaceuticals says it has elected to file voluntary petitions under Chapter 11…

FinancialKrystexxaMergers & AcquisitionsPharmaceuticalSavient Pharmaceuticals

Astellas links with Mitokyne on mitochondria-related therapies

Astellas links with Mitokyne on mitochondria-related therapies

07-10-2013

Japanese drug major Astellas Pharma and USA-based start-up Mitokyne have entered into an exclusive R&D…

Astellas PharmaFinancialLicensingMergers & AcquisitionsMitokynePharmaceuticalResearch

BTG ups full year guidance following acquisitions

03-10-2013

UK specialist health care company BTG has provided an update for the six months ended September 30, 2013,…

BTGFinancialMergers & AcquisitionsPharmaceutical

First-half 2013 sees fall in licensing, says Evaluate

20-09-2013

Despite a positive start to the year characterized by healthy initial public offering (IPO) activity…

FinancialLicensingMergers & AcquisitionsPharmaceutical

Stada Arz buys UK OTC manufacturer

21-08-2013

German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

1 to 25 of 79 results

Back to top